arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2501.19405cs.HCcs.CEcs.ET
收藏

人与精准医学交互:公众对用于遗传健康预测的多基因风险评分的看法

Human-Precision Medicine Interaction: Public Perceptions of Polygenic Risk Score for Genetic Health Prediction

Yuhao Sun, Albert Tenesa, John Vines

AI总结:

该研究通过混合方法探索公众对多基因风险评分(PRS)的看法,识别出十个关键障碍与五个主题,提出负责任PRS框架设计启示,并引入“人与精准医学交互”(HPMI)概念以应对精准医学复杂性。

摘要:

精准医学(PM)通过基于个体特征定制治疗方案,改变了传统的“一刀切”模式,并且是人机交互(HCI)在数字健康领域的一个新兴研究课题。作为PM的核心要素,多基因风险评分(PRS)利用基因数据来预测个体的疾病风险。尽管具有潜力,但PRS的采用面临着数据包容性、心理影响和公众信任等障碍。我们开展了一项混合方法研究,以探索人们如何看待PRS,该研究由对英国参与者的问卷调查(n=254)和访谈(n=11)组成。访谈辅以采用ContraVision技术的交互式故事板,以引发更深刻的反思与讨论。我们识别出PRS采用的十个关键障碍和五个主题,并提出了负责任的PRS框架的设计启示。为了应对PRS的复杂性并改善更广泛的PM实践,我们引入了“人与精准医学交互”(HPMI)这一术语,它整合、调整并扩展了HCI方法,以更好地应对这些挑战。

英文摘要:

Precision Medicine (PM) transforms the traditional "one-drug-fits-all" paradigm by customising treatments based on individual characteristics, and is an emerging topic for HCI research on digital health. A key element of PM, the Polygenic Risk Score (PRS), uses genetic data to predict an individual's disease risk. Despite its potential, PRS faces barriers to adoption, such as data inclusivity, psychological impact, and public trust. We conducted a mixed-methods study to explore how people perceive PRS, formed of surveys (n=254) and interviews (n=11) with UK-based participants. The interviews were supplemented by interactive storyboards with the ContraVision technique to provoke deeper reflection and discussion. We identified ten key barriers and five themes to PRS adoption and proposed design implications for a responsible PRS framework. To address the complexities of PRS and enhance broader PM practices, we introduce the term Human-Precision Medicine Interaction (HPMI), which integrates, adapts, and extends HCI approaches to better meet these challenges.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑